Lung cancer is the leading cause of cancer-related mortality in the United States and
worldwide. Early detection of lung cancer is an important opportunity for decreasing …

Chronic obstructive pulmonary disease (COPD) and lung cancer are devastating pulmonary
diseases that commonly coexist and present a number of clinical challenges. COPD confers …

Background: Lung cancer screening (LCS) has the potential to reduce the risk of lung
cancer death in healthy individuals, but the impact of coexisting chronic illnesses on LCS …

Lung cancer and chronic obstructive pulmonary disease (COPD) are two intimately related
diseases, with great impact on public health. Annual screening using low-dose computed …

Rationale: Although epidemiological studies consistently show that chronic obstructive
pulmonary disease is associated with an increased risk of lung cancer, debate exists as to …

A North American trial reported a significant reduction of lung cancer mortality and overall
mortality as a result of annual screening using low-dose computed tomography (LDCT) …

Background Lung cancer combined by chronic obstructive pulmonary disease (LC-COPD) is
a common comorbidity and their interaction with each other poses significant clinical …

Lung cancer causes an estimated 1.6 million deaths each year, being the leading cause of
cancer-related deaths in the world. Late diagnosis and, in some cases, the high …

Abstract Chronic Obstructive Pulmonary Disease (COPD) phenotypes have become
increasingly recognized as important for grouping patients with similar presentation and/or …

Introduction Lung cancer (LC) is the leading cause of death from cancer. Early diagnosis of
LC is of paramount importance in terms of prognosis. The health authorities of most …